Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate CancerSvend O. Freytag, Benjamin Movsas, Hans Stricker et al.|International Journal of Radiation Oncology*Biology*Physics|2014Cited by 86
pT1 SUBSTAGING IN RENAL CELL CARCINOMA: VALIDATION OF THE 2002 TNM STAGING MODIFICATION OF MALIGNANT RENAL EPITHELIAL TUMORSMohamed E. Salama, Mariza de Peralta‐Venturina, Khurshid A. Guru et al.|The Journal of Urology|2005Cited by 35
Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, <i>ETV1</i> , and <i>ETV4</i> on whole‐mount radical prostatectomy tissueZhichun Lu, Nallasivam Palanisamy, Pavithra D. Arachchige et al.|The Prostate|2019Cited by 26
Pseudogene Associated Recurrent Gene Fusion in Prostate CancerBalabhadrapatruni V. S. K. Chakravarthi, Nallasivam Palanisamy, Pavithra Dedigama-Arachchige et al.|Neoplasia|2019Cited by 23
Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridizationPavithra Dedigama-Arachchige, Nallasivam Palanisamy, Shannon Carskadon et al.|Modern Pathology|2020Cited by 11